Eliyahu Sharon Kalif - Feb 13, 2022 Form 4 Insider Report for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

Signature
/s/ Dov Bergwerk as attorney-in-fact for Eliyahu Sharon Kalif
Stock symbol
TEVA
Transactions as of
Feb 13, 2022
Transactions value $
$0
Form type
4
Date filed
2/15/2022, 06:28 AM
Next filing
Mar 2, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TEVA Ordinary Shares Options Exercise +6.63K +35.97% 25.1K Feb 13, 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TEVA Restricted Share Units Options Exercise $0 -6.63K -33.33% $0.00 13.3K Feb 13, 2022 Ordinary Shares 6.63K Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
F2 Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
F3 Restricted share units were granted on February 13, 2020, with 6,629 vesting on each of February 13, 2022 and February 13, 2023 and 6,630 vesting on February 13, 2024.